ELIZABETH PETITT: Open Payments
NPI 1104087295 · PASADENA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 91 payments from 22 companies in 2025. Trend: 2023 $1,696 · 2024 $2,224 · 2025 $2,016
Food & beverage: $1,949Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $420 |
| Novartis Pharmaceuticals Corporation | 15 | $403 |
| Janssen Biotech, Inc. | 7 | $211 |
| Organon LLC | 8 | $129 |
| Incyte Corporation | 5 | $112 |
| PFIZER INC. | 1 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $88 |
| Lilly USA, LLC | 4 | $76 |
| Amgen Inc. | 4 | $76 |
| Galderma Laboratories, L.P. | 3 | $56 |
Products named: COSENTYX, TREMFYA, SKYRIZI, RINVOQ, OPZELURA, CIBINQO, DUPIXENT, OTEZLA.
Industry payments across TX — which companies pay providers there.
